- 1. EBV Infection
- [Infection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY). ( MSH )] (UMLS (NCI) C0149678) =Disease or Syndrome =Herpesviridae disease;
Tumor Virus Infections =Acute B Cell Lymphocytic Leukemia;
glandular fever;
Hairy Leukoplakia of Mouth | - 7. EBV Related Malignancy
- (UMLS (NCI) C1333432) EBV-Related Malignancy;
Epstein-Barr Virus Related Malignancy;
Epstein-Barr Virus-Related Malignancy;
Epstein-Barr Virus-Related Malignant Neoplasm;
=Neoplastic Process; ;
|
- 2. EBV Related Burkitt's Lymphoma
- (UMLS (NCI) C1333427) EBV-Related Burkitt's Lymphoma;
Epstein-Barr Virus-Related Burkitt Lymphoma;
Epstein-Barr Virus-Related Burkitt's Lymphoma =Neoplastic Process; ;
| - 8. EBV Related Non-Hodgkin's Lymphoma
- (UMLS (NCI) C1333433) EBV-Related Non-Hodgkin's Lymphoma;
Epstein-Barr Virus Related Non-Hodgkin's Lymphoma;
Epstein-Barr Virus-Related Non-Hodgkin Lymphoma;
Epstein-Barr Virus-Related Non-Hodgkin's Lymphoma;
=Neoplastic Process; ;
|
- 3. EBV Related Carcinoma
- (UMLS (NCI) C1333428) EBV-Related Carcinoma;
Epstein-Barr Virus Related Carcinoma;
Epstein-Barr Virus-Related Carcinoma =Neoplastic Process; ;
| - 9. EBV-Related PTLD
- (UMLS (NCI) C1333434) Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder =Neoplastic Process; ;
|
- 4. EBV Related Clonal PTLD
- (UMLS (NCI) C1333429) EBV-Related Clonal PTLD;
Epstein-Barr Virus-Related Clonal Post-Transplant Lymphoproliferative Disorder;
=Neoplastic Process; ;
| - 10. EBV-specific CTL
- [A white blood cell that is derived from a lymphocyte stem cell matured in the thymus and characterized by a CD8 marker on the surface and an antigen-specific Epstein Barr virus T cell receptor. ( NCI )] (UMLS (NCI) C0393073) =Cell
|
- 5. EBV Related Hodgkin's Lymphoma
- (UMLS (NCI) C1333430) EBV-Related Hodgkin's Lymphoma;
Epstein-Barr Virus Related Hodgkin's Lymphoma;
Epstein-Barr Virus-Related Hodgkin Lymphoma;
Epstein-Barr Virus-Related Hodgkin's Lymphoma;
=Neoplastic Process; ;
| - 11. EBV-Specific Cytotoxic T-Lymphocytes
- [A preparation of cytotoxic T-lymphocytes (CTL) specifically reactive to Epstein-Barr virus (EBV) latent membrane protein-2A (LMP2A) with potential antineoplastic activity. T-lymphocytes are exposed ex vivo to dendritic cells (DCs) transfected with a replication-deficient adenovirus encoding EBV LMP2A. These LMP2A-specific CTLs are subsequently exposed to EBV infected cells transfected with adenovirus encoding LMP2A, thereby further stimulating CTLs. Administered into patients with EBV-positive tumors, LMP2A-specific CTLs target LMPA-positive cells, resulting in cell lysis and inhibition of cancer cell proliferation. EBV LMP2A is expressed in various EBV-positive malignancies, including nasopharyngeal carcinoma, EBV-positive Hodgkin's and non-Hodgkin's lymphomas. ( NCI )] (UMLS (NCI) C1328049) LMP2A-Specific CTL;
LMP2A-Specific Cytotoxic T-Lymphocytes =Cell; Pharmacologic Substance |
- 6. EBV Related Lymphoma
- (UMLS (NCI) C1333431) EBV-Related Lymphoma;
Epstein-Barr Virus Related Lymphoma;
Epstein-Barr Virus-Related Lymphoma =Neoplastic Process; ;
| |
home
